BG104018A - Device for projection mammography - Google Patents

Device for projection mammography

Info

Publication number
BG104018A
BG104018A BG104018A BG10401899A BG104018A BG 104018 A BG104018 A BG 104018A BG 104018 A BG104018 A BG 104018A BG 10401899 A BG10401899 A BG 10401899A BG 104018 A BG104018 A BG 104018A
Authority
BG
Bulgaria
Prior art keywords
mrt
projection mammography
sensitivity
impairments
contrast
Prior art date
Application number
BG104018A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ulrich Speck
Brenndorff Irtel Von
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG104018A publication Critical patent/BG104018A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Holo Graphy (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Liquid Crystal (AREA)
BG104018A 1997-06-20 1999-12-15 Device for projection mammography BG104018A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97250190A EP0885616A1 (de) 1997-06-20 1997-06-20 Verwendung von intravenösen Kontrastmitteln sowie Vorrichtungen für die Projektionsmammographie
PCT/EP1998/003659 WO1998058585A1 (de) 1997-06-20 1998-06-19 Vorrichtungen für die projektionsmammographie

Publications (1)

Publication Number Publication Date
BG104018A true BG104018A (en) 2000-05-31

Family

ID=8229158

Family Applications (2)

Application Number Title Priority Date Filing Date
BG104018A BG104018A (en) 1997-06-20 1999-12-15 Device for projection mammography
BG104017A BG64895B1 (bg) 1997-06-20 1999-12-15 Използване на венозно контрастно средство за производство на диагностично средство за проекционна мамография

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG104017A BG64895B1 (bg) 1997-06-20 1999-12-15 Използване на венозно контрастно средство за производство на диагностично средство за проекционна мамография

Country Status (28)

Country Link
US (2) US20020031475A1 (pl)
EP (3) EP0885616A1 (pl)
JP (3) JP4664449B2 (pl)
KR (2) KR100582980B1 (pl)
CN (2) CN1263449A (pl)
AT (1) ATE229820T1 (pl)
AU (2) AU8337998A (pl)
BG (2) BG104018A (pl)
BR (2) BR9810215A (pl)
CA (2) CA2294187A1 (pl)
CZ (1) CZ298462B6 (pl)
DE (1) DE59806743D1 (pl)
DK (1) DK0994729T3 (pl)
HK (1) HK1029759A1 (pl)
HU (2) HU225522B1 (pl)
IL (2) IL133574A (pl)
NO (2) NO996292L (pl)
NZ (2) NZ501603A (pl)
PL (2) PL337286A1 (pl)
RS (1) RS49734B (pl)
RU (1) RU2194533C2 (pl)
SI (2) SI20148A (pl)
SK (2) SK181199A3 (pl)
TR (2) TR199903144T2 (pl)
UA (1) UA71895C2 (pl)
WO (2) WO1998058585A1 (pl)
YU (1) YU66299A (pl)
ZA (1) ZA985395B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10118792B4 (de) * 2001-04-05 2005-12-22 Schering Ag Anordnung zur Aufnahme von Projektionsmammogrammen und Verwendung der Anordnung für die Projektionsmammographie
FR2823969B1 (fr) * 2001-04-30 2003-12-26 Ge Med Sys Global Tech Co Llc Procede de prelevement d'un tissu au cours d'un examen par rayons x et dispositif de mise en oeuvre
DE102005033235A1 (de) * 2005-07-15 2007-01-18 Siemens Ag Verfahren zur Visualisierung eines vaskulären Einsatzstücks
US20080167552A1 (en) * 2007-01-04 2008-07-10 General Electric Company System and method of generating an image of a contrast agent injected into an imaged subject
FR2927719B1 (fr) * 2008-02-19 2010-03-26 Gen Electric Procede de traitement d'images obtenues par tomosynthese et dispositif associe
US8315449B2 (en) * 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
JP2012055549A (ja) * 2010-09-10 2012-03-22 Fujifilm Corp バイオプシ用ファントム
FR2967888B1 (fr) * 2010-11-26 2012-12-21 Gen Electric Procede de galactographie et mammographe pour l'execution dudit procede
US9651138B2 (en) 2011-09-30 2017-05-16 Mtd Products Inc. Speed control assembly for a self-propelled walk-behind lawn mower
DE102012217301B4 (de) 2012-09-25 2021-10-14 Bayer Pharma Aktiengesellschaft Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination
EA036245B1 (ru) * 2017-10-26 2020-10-16 Казахский научно-исследовательский институт онкологии и радиологии Способ диагностики рака молочной железы
EP3498306A1 (de) * 2017-12-16 2019-06-19 Bionorica SE Extrakte aus vitex agnus castus zur behandlung und diagnose von brustkrebs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
DE3688613T2 (de) * 1985-11-18 1994-01-13 Access Pharma Inc Polychelierende stoffe für abbildung- und spektralerhöhung (und spektrale verschiebung).
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5844965A (en) * 1989-11-24 1998-12-01 Thomas Jefferson University Method and apparatus for using film density measurements of a radiograph to monitor the reproducibility of X-ray exposure parameters of a mammography unit
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4417628C1 (de) * 1994-05-19 1995-09-28 Siemens Ag Verfahren zur adaptiven Rauschverminderung für digitale Bildsequenzen
SK68897A3 (en) * 1994-11-30 1998-10-07 Schering Ag Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
US5756066A (en) * 1995-06-07 1998-05-26 Schering Aktiengesellschaft Iodine-containing peptides
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
US6009342A (en) * 1997-02-28 1999-12-28 The Regents Of The University Of California Imaging method for the grading of tumors

Also Published As

Publication number Publication date
IL133574A0 (en) 2001-04-30
CZ460999A3 (cs) 2000-04-12
NO996291D0 (no) 1999-12-17
CZ298462B6 (cs) 2007-10-10
BG64895B1 (bg) 2006-08-31
NO996291L (no) 1999-12-17
HUP0003097A1 (hu) 2001-01-29
HU225522B1 (en) 2007-01-29
CN1263474A (zh) 2000-08-16
PL191807B1 (pl) 2006-07-31
US20050008574A1 (en) 2005-01-13
AU8337998A (en) 1999-01-04
WO1998058679A1 (de) 1998-12-30
YU66299A (sh) 2002-09-19
BR9810205A (pt) 2000-08-08
RS49734B (sr) 2008-04-04
KR100582980B1 (ko) 2006-05-24
ZA985395B (en) 1999-04-07
JP2002505679A (ja) 2002-02-19
JP4664449B2 (ja) 2011-04-06
KR20010013979A (ko) 2001-02-26
SK282716B6 (sk) 2002-11-06
NO996292D0 (no) 1999-12-17
CN1212862C (zh) 2005-08-03
UA71895C2 (en) 2005-01-17
JP2002504843A (ja) 2002-02-12
PL337286A1 (en) 2000-08-14
DK0994729T3 (da) 2003-03-10
NO315638B1 (no) 2003-10-06
BG104017A (en) 2000-05-31
EP0994729B1 (de) 2002-12-18
NO996292L (no) 1999-12-17
YU66199A (sh) 2002-10-18
CA2294502C (en) 2009-03-31
TR199903140T2 (xx) 2000-05-22
US20020031475A1 (en) 2002-03-14
IL133574A (en) 2004-03-28
NZ501603A (en) 2002-02-01
WO1998058585A1 (de) 1998-12-30
CA2294187A1 (en) 1998-12-30
ATE229820T1 (de) 2003-01-15
CA2294502A1 (en) 1998-12-30
HUP0003097A3 (en) 2003-07-28
BR9810215A (pt) 2000-08-08
EP0885616A1 (de) 1998-12-23
SI20148A (sl) 2000-08-31
JP2011012074A (ja) 2011-01-20
PL337287A1 (en) 2000-08-14
HUP0003096A1 (hu) 2001-01-29
HK1029759A1 (en) 2001-04-12
SK181199A3 (en) 2000-07-11
RU2194533C2 (ru) 2002-12-20
EP0994729A1 (de) 2000-04-26
NZ501602A (en) 2002-02-01
IL133573A0 (en) 2001-04-30
CN1263449A (zh) 2000-08-16
DE59806743D1 (de) 2003-01-30
EP0991356A1 (de) 2000-04-12
AU747033B2 (en) 2002-05-09
TR199903144T2 (xx) 2000-08-21
SK171299A3 (en) 2000-05-16
SI20152A (sl) 2000-08-31
KR20010013980A (ko) 2001-02-26
AU8627198A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
BR0206160A (pt) Uso de anticorpos anti-tnf como medicamentos no tratamento de distúrbios sépticos de pacientes anêmicos
BG104018A (en) Device for projection mammography
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
IL176689A0 (en) Use of memantine for the preparation of a medicament for the treatment of mild and mild-to-moderate alzheimer's disease
EP1140170A4 (en) NOVEL AGENTS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF EYE DISORDERS
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
HK1016877A1 (en) Bioactivated diagnostic imaging contrast agents.
CR10244A (es) Terapia tumoral con un anticuerpo contra el factor de crecimiento endotelial vascular y un anticuerpo contra el receptor del factor de crecimiento epitelial tipo 2 humano
PT777484E (pt) Formulacoes intravenosas de alendronato
WO1992019213A3 (en) Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
JOP20220092A1 (ar) جسم مضاد لبيتا-النشواني لعلاج مرض الزهايمر
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
NO960974D0 (no) Farmasöytisk preparat for behandling av optisk nervesykdom med prostansyreforbindelser
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
MX2022013923A (es) Metodos para tratar la enfermedad de crohn con el anticuerpo especifico anti-il23.
KR960028907A (ko) 암환자를 치료하기 위한 세트랄린의 용도
FR2736163B1 (fr) Methode d'obtention, en medecine nucleaire, d'une image du corps d'un patient corrigee des troncatures
Kumar Three phase bone scan interpretation based upon vascular endothelial response
McLaughlin et al. Auditory localization and judgments of straight ahead during adaptation to prism
AU6342101A (en) Agents and methods for increasing brain chaperonin levels
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
MD1091G2 (ro) Metodă de evaluare a stării circulaţiei limfatice în ductul toracic limfatic la bolnavii cu ciroză hepatică şi ascită
Kim et al. Impacts of Fatigue, Anxiety, Depression, and Cognitive Function on the Quality of Life in Gastrointestinal Cancer Patients Receiving Chemotherapy
MALLARD Some call it laziness: I call it deep thought (with apologies to Garfield)